Form 25-NSE GLAXOSMITHKLINE PLC Filed by: NEW YORK STOCK EXCHANGE LLC

    X0203

    
        0000876661
        NEW YORK STOCK EXCHANGE LLC
    

    
        0001131399
        GLAXOSMITHKLINE PLC
        001-15170
        

            GSK House 980 Great West Road
            Brentford
            
            
            TW8 9GS
        
        +44 20 8047 5000
    

    Guarantor of Floating Rate Notes due 2021

    17 CFR 240.12d2-2(a)(2)

    
        Christopher Rances
        Senior Analyst
        2021-05-13
    

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES

The New York Stock Exchange hereby notifies the SEC of its intention to remove the guarantor of the entire class of the stated securities from listing and registration on the Exchange at the opening of business on May 25, 2021, pursuant to the provisions of Rule 12d2-2 (a).

[ X ] 17 CFR 240.12d2-2(a)(2) That the entire class of this security was redeemed or paid at maturity or retirement on May 14, 2021.

The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on May 14, 2021.

You May Also Be Interested In

• GSK (GSK) call put ratio 12 calls to 1 put with focus on April weekly (26) 41 calls
• Interius BioTherapeutics to Present In Vivo CAR Data in Oncology and Autoimmunity Programs at the American Society of Gene and Cell Therapy 27th Annual Meeting
• TÜV Rheinland reports strong growth in 2023 due to company acquisitions and revenues